58.35
-1.94
(-3.22%)
As of 1:07:59 PM EDT. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 3,525,240 | 11 |
Sales | 3,026,568 | 12 |
Net Shares Purchased (Sold) | 498,672 | 23 |
Total Insider Shares Held | 239.03M | -- |
% Net Shares Purchased (Sold) | 0.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
RICKARD KATHLEEN A Officer | Sale at price 67.60 per share. | Direct | 5,358,246 | Mar 12, 2025 |
EBSWORTH DAVID R Director | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 26, 2025 |
EBSWORTH DAVID R Director | Conversion of Exercise of derivative security at price 0.50 - 2.67 per share. | Direct | 600,060 | Feb 26, 2025 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
HAHN MARK W Chief Financial Officer | Sale at price 39.85 - 40.50 per share. | Direct | 35,374,337 | Dec 6, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 39.85 - 40.50 per share. | Direct | 34,910,944 | Dec 6, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 39.63 - 39.90 per share. | Direct | 4,491,194 | Dec 2, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 39.68 per share. | Direct | 95,232 | Nov 26, 2024 |
EBSWORTH DAVID R Director | Purchase at price 35.66 per share. | Direct | 713,200 | Nov 18, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 39.87 per share. | Direct | 95,688 | Nov 11, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 39.87 per share. | Direct | 95,688 | Nov 11, 2024 |
EBSWORTH DAVID R Director | Purchase at price 37.59 per share. | Direct | 1,479,542 | Nov 6, 2024 |
ACKERMANN CHRISTINA M Director | Purchase at price 37.59 per share. | Direct | 1,574,269 | Nov 6, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 34.98 - 38.15 per share. | Direct | 4,792,012 | Nov 4, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 34.98 - 38.15 per share. | Direct | 5,231,736 | Nov 4, 2024 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
FISHER ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 30, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 33.86 - 34.43 per share. | Direct | 4,975,377 | Oct 25, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 33.86 - 34.93 per share. | Direct | 4,983,287 | Oct 25, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 34.63 - 34.97 per share. | Direct | 17,896,329 | Oct 22, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 30.15 per share. | Direct | 18,090,000 | Sep 11, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 24.68 - 26.73 per share. | Direct | 10,688,720 | Aug 13, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 24.68 - 26.73 per share. | Direct | 10,688,720 | Aug 13, 2024 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
RICKARD KATHLEEN A Officer | Sale at price 15.69 per share. | Direct | 568,731 | May 3, 2024 |
RICKARD KATHLEEN A Officer | Sale at price 18.31 per share. | Direct | 663,701 | Feb 5, 2024 |
POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
EDWARDS MARTIN Director | Purchase at price 14.73 per share. | Direct | 496,931 | Nov 20, 2023 |
EBSWORTH DAVID R Director | Purchase at price 15.12 per share. | Direct | 2,419,200 | Nov 6, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 15.37 per share. | Direct | 903,018 | Nov 3, 2023 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
POLL CLAIRE LOUISE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
HAHN MARK W Chief Financial Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 19.04 - 20.04 per share. | Direct | 1,601,412 | Aug 7, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 19.04 - 20.04 per share. | Direct | 966,968 | Aug 7, 2023 |
POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 7, 2023 |
HAHN MARK W Chief Financial Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 20.64 - 21.45 per share. | Direct | 706,614 | Aug 2, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 20.64 - 21.45 per share. | Direct | 666,241 | Aug 2, 2023 |
GUPTA RISHI Director | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
13.42
-13.53%
CYTK Cytokinetics, Incorporated
41.20
+2.36%
MDGL Madrigal Pharmaceuticals, Inc.
328.42
-1.85%
AXSM Axsome Therapeutics, Inc.
108.41
-1.22%
SRRK Scholar Rock Holding Corporation
31.54
-3.07%
BBIO BridgeBio Pharma, Inc.
34.72
+0.29%
SWTX SpringWorks Therapeutics, Inc.
43.56
-6.36%
INSM Insmed Incorporated
73.52
+0.10%
TGTX TG Therapeutics, Inc.
39.46
-0.90%
RNA Avidity Biosciences, Inc.
28.52
-4.22%